Skip to Main Content

Paper Details

Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
Open Forum Infect Dis
53
2021
Author NameAffiliation
Donald M YealyUniversity of Pittsburgh School of Medicine
David T HuangUniversity of Pittsburgh School of Medicine
David T HuangUniversity of Pittsburgh School of Medicine
David T HuangClinical Research Investigation and Systems Modeling of Acute Illness (CRISMA) Center, University of Pittsburgh School of Medicine
Christopher W SeymourUniversity of Pittsburgh School of Medicine
Christopher W Seymour
Christopher W SeymourClinical Research Investigation and Systems Modeling of Acute Illness (CRISMA) Center, University of Pittsburgh School of Medicine
Derek C Angus
Derek C AngusUniversity of Pittsburgh School of Medicine
Derek C AngusClinical Research Investigation and Systems Modeling of Acute Illness (CRISMA) Center, University of Pittsburgh School of Medicine
Graham M SnyderUniversity of Pittsburgh School of Medicine
  • 1 - 11

Datasets

Release 1.2